Drug Discovery news has published an article on CDD’s work with the St. Jude Children’s Research Hospital. From the article:
A collaboration to identify and develop drugs for resistant strains of malaria draws on an unusual combination of resources: U.S. Army research from 1946 plus 21st century informatics and lab technology.
The joint work on malaria began about two years ago between Collaborative Drug Discovery Inc., (CDD) and the Department of Chemical Biology and Therapeutics at St. Jude Children’s Research Hospital. CDD created a database of over 12,000 molecules from the 61-year-old, two-volume “A Survey of Malaria Drugs,” edited by Frederick Y. Wiselogle.
Other posts you might be interested in
View All Posts
Webinars
1 min
September 30, 2025
AI-Driven Drug Discovery to Address Antimicrobial Resistance and Glioblastoma: Stoked Bio's MOSAIC Platform Approach
Read More
CDD Vault Snack
4 min
September 29, 2025
Vault Snack #31 – Chemically-Aware Antibody and Antibody Drug Conjugate (ADC) Registration
Read More
CDD Vault Updates
2 min
September 25, 2025
CDD Vault Update (Sept #4 2025): Publication Ready Plots and ELN to Inventory Connections
Read More